KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Change in Cash (2016 - 2025)

Historic Change in Cash for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $47.0 million.

  • Teladoc Health's Change in Cash fell 4110.76% to $47.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$519.5 million, marking a year-over-year decrease of 34571.79%. This contributed to the annual value of $177.9 million for FY2024, which is 1299.97% down from last year.
  • According to the latest figures from Q3 2025, Teladoc Health's Change in Cash is $47.0 million, which was down 4110.76% from -$518.2 million recorded in Q2 2025.
  • Teladoc Health's 5-year Change in Cash high stood at $91.8 million for Q4 2023, and its period low was -$518.2 million during Q2 2025.
  • Over the past 5 years, Teladoc Health's median Change in Cash value was $46.3 million (recorded in 2022), while the average stood at -$281842.1.
  • In the last 5 years, Teladoc Health's Change in Cash skyrocketed by 47236.11% in 2023 and then tumbled by 90042.79% in 2025.
  • Quarter analysis of 5 years shows Teladoc Health's Change in Cash stood at $69.8 million in 2021, then tumbled by 77.01% to $16.0 million in 2022, then skyrocketed by 472.36% to $91.8 million in 2023, then tumbled by 36.48% to $58.3 million in 2024, then dropped by 19.49% to $47.0 million in 2025.
  • Its last three reported values are $47.0 million in Q3 2025, -$518.2 million for Q2 2025, and -$106.6 million during Q1 2025.